Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown

Pharma Giants: Walgreens vs Ascendis Gross Profit Trends (2014-2023)

__timestampAscendis Pharma A/SWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20141398300021569000000
Thursday, January 1, 2015811800026753000000
Friday, January 1, 2016460600029874000000
Sunday, January 1, 2017153000029162000000
Monday, January 1, 20181058100030792000000
Tuesday, January 1, 20191337500028159000000
Wednesday, January 1, 2020695300026077000000
Friday, January 1, 2021425500028067000000
Saturday, January 1, 20223903700028266000000
Sunday, January 1, 202322232300027072000000
Monday, January 1, 202431938300026524000000
Loading chart...

Data in motion

Walgreens Boots Alliance vs Ascendis Pharma: A Decade of Gross Profit Trends

In the ever-evolving landscape of the pharmaceutical and retail sectors, Walgreens Boots Alliance, Inc. and Ascendis Pharma A/S have showcased contrasting trajectories in gross profit performance from 2014 to 2023. Walgreens, a stalwart in the retail pharmacy space, consistently reported robust gross profits, peaking in 2018 with a 43% increase from 2014. In contrast, Ascendis Pharma, a biotech innovator, experienced a dramatic surge in 2023, with gross profits skyrocketing by over 1,500% compared to 2014. This stark difference highlights the dynamic nature of the industry, where established giants and emerging players navigate unique challenges and opportunities. While Walgreens faced a slight decline in recent years, Ascendis's growth trajectory underscores the potential of biotech advancements. Missing data for 2024 suggests an evolving narrative, inviting stakeholders to anticipate future developments.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025